Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
Adoptive T cell therapy (ACT) holds great promise for cancer treatment. One approach, which has regained wide interest in recent years, employs antitumor T cells isolated from tumor lesions (“tumor-infiltrating lymphocytes” or TIL). It is now appreciated that a considerable proportion of anti-melano...
Main Authors: | Hadas Weinstein-Marom, Gideon Gross, Michal Levi, Hadar Brayer, Jacob Schachter, Orit Itzhaki, Michal J. Besser |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.584148/full |
Similar Items
-
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
by: Meir Rozenbaum, et al.
Published: (2020-07-01) -
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
by: Marina Martinez, et al.
Published: (2019-02-01) -
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
by: Sivan Seliktar-Ofir, et al.
Published: (2017-10-01) -
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
by: Sharon Yunger, et al.
Published: (2019-12-01) -
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
by: Jan A. Rath, et al.
Published: (2020-06-01)